During the last session, Hoth Therapeutics Inc (NASDAQ:HOTH)’s traded shares were 9.04 million, with the beta value of the company hitting 0.77. At the end of the trading day, the stock’s price was $0.83, reflecting an intraday gain of 1.05% or $0.01. The 52-week high for the HOTH share is $1.73, that puts it down -108.43 from that peak though still a striking 30.12% gain since the share price plummeted to a 52-week low of $0.58. The company’s market capitalization is $5.71M, and the average intraday trading volume over the past 10 days was 1.28 million shares, and the average trade volume was 3.67 million shares over the past three months.
Hoth Therapeutics Inc (HOTH) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. HOTH has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Hoth Therapeutics Inc (NASDAQ:HOTH) trade information
Hoth Therapeutics Inc (HOTH) registered a 1.05% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 1.05% in intraday trading to $0.83, hitting a weekly high. The stock’s 5-day price performance is -5.34%, and it has moved by -3.88% in 30 days. Based on these gigs, the overall price performance for the year is -22.75%. The short interest in Hoth Therapeutics Inc (NASDAQ:HOTH) is 0.62 million shares and it means that shorts have 0.44 day(s) to cover.
Hoth Therapeutics Inc (HOTH) estimates and forecasts
Statistics show that Hoth Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Hoth Therapeutics Inc (HOTH) shares have gone down -31.12% during the last six months, with a year-to-date growth rate more than the industry average at 48.70% against 18.10.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 15.18%. While earnings are projected to return 44.78% in 2024.
HOTH Dividends
Hoth Therapeutics Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Hoth Therapeutics Inc (NASDAQ:HOTH)’s Major holders
Hoth Therapeutics Inc insiders own 0.92% of total outstanding shares while institutional holders control 4.84%, with the float percentage being 4.88%.
